The Biotech Growth Trust – equity proposition

The Biotech Growth Trust – equity proposition

The Biotech Growth Trust — 2 videos in collection

More on this equity

The Biotech Growth Trust (BIOG) seeks capital appreciation through investing in the worldwide biotechnology industry. Performance is measured against its benchmark index, the NASDAQ Biotechnology Total Return Index (sterling adjusted).

We highlight the key points of BIOG’s investment story.

  1. The trust focuses on capital growth via investment in the global biotechnology industry.
  2. Biotech industry fundamentals are favourable.
  3. BIOG’s small-cap bias is likely to benefit its returns in a declining interest rate environment.
  4. The trust’s managers can draw on OrbiMed’s extensive resources.

If you would like to find out more about The Biotech Growth Trust, please visit our website.


You may also be interested in these:

sharesoc pic

Investment Companies

ShareSoc webinar – The Biotech Growth Trust

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free